Statements (29)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:company
|
gptkbp:acquiredBy |
gptkb:VWR_International
|
gptkbp:category |
gptkb:chemical_compound
Fortune 500 company life sciences company |
gptkbp:CEO |
gptkb:Michael_Stubblefield
|
gptkbp:founded |
1904
|
gptkbp:founder |
gptkb:John_Townsend_Baker
|
gptkbp:headquartersLocation |
gptkb:Radnor,_Pennsylvania,_United_States
|
https://www.w3.org/2000/01/rdf-schema#label |
Avantor
|
gptkbp:industry |
life sciences
chemicals |
gptkbp:ISIN |
US05352A1007
|
gptkbp:numberOfEmployees |
~14,500
|
gptkbp:parentCompany |
New Mountain Capital (prior to IPO)
|
gptkbp:products |
industrial equipment
consumables laboratory chemicals biopharmaceutical ingredients |
gptkbp:revenue |
~$7.5 billion (2023)
|
gptkbp:servesArea |
worldwide
|
gptkbp:stockExchange |
gptkb:New_York_Stock_Exchange
|
gptkbp:stockSymbol |
gptkb:AVTR
|
gptkbp:type |
gptkb:public_company
|
gptkbp:website |
https://www.avantorsciences.com/
|
gptkbp:bfsParent |
gptkb:New_Mountain_Capital
gptkb:Thermo_Fisher_Scientific gptkb:VWR_International |
gptkbp:bfsLayer |
6
|